Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma
- Author
- GISSELBRECHT, Christian; LEPAGE, Eric; HERMINE, Olivier; REYES, Félix; MOLINA, Thierry; QUESNEL, Bruno; FILLET, Georges; LEDERLIN, Pierre; COIFFIER, Bertrand; TILLY, Hervé; GABARRE, Jean; GUILMIN, Francoise
Groupe d'Etude des Lymphomes de l'Adulte, France - Source
Journal of clinical oncology. 2002, Vol 20, Num 10, pp 2472-2479 ; ref : 37 ref
- ISSN
- 0732-183X
- Scientific domain
- Medical oncology
- Publisher
- Lippincott Williams & Wilkins, Baltimore, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Agent alkylant Alcaloïde Anthracyclines Anticancéreux Antimitotique Antimétabolite Association médicamenteuse Autogreffe Bléomycine Cellule hématopoïétique Cellule souche Chimiothérapie Corticostéroïde Cyclophosphamide Cytarabine DNA topoisomerase (ATP-hydrolysing) Dose forte Epirubicine Etoposide Greffe Haute malignité Homme Inhibiteur enzyme Lymphome non hodgkinien Melphalan Moutarde à l'azote Oxazaphosphinane dérivé Podophyllotoxine dérivé Prednisone Pyrimidine nucléoside Sang Traitement associé Urée(1-[2-chloroéthyl]-1-nitroso) Vindésine Première intention Enzyme Hémopathie maligne Isomerases Lymphoprolifératif syndrome
- Keyword (en)
- Alkylating agent Alkaloid Anthracyclins Antineoplastic agent Antimitotic Antimetabolic Drug combination Autograft Bleomycin Hematopoietic cell Stem cell Chemotherapy Corticosteroid Cyclophosphamide Cytarabine DNA topoisomerase (ATP-hydrolysing) High dose Epirubicin Etoposide Graft High malignancy Human Enzyme inhibitor Non Hodgkin lymphoma Melphalan Nitrogen mustard Oxazaphosphinane derivatives Podophyllotoxine derivatives Prednisone Pyrimidine nucleoside Blood Combined treatment Vindesine First line Enzyme Malignant hemopathy Isomerases Lymphoproliferative syndrome
- Keyword (es)
- Agente alquilante Alcaloide Antraciclinas Anticanceroso Antimitótico Antimetabólito Asociación medicamentosa Autoinjerto Bleomicina Célula hematopoyética Célula primitiva Quimioterapia Corticoesteroide Ciclofosfamida Citarabina DNA topoisomerase (ATP-hydrolysing) Dosis fuerte Epirubicina Etopósido Injerto Alta malignidad Hombre Inhibidor enzima Linfoma no Hodgkin Melfalán Mostaza al nitrógeno Oxazafosfinano derivado Podofilotoxina derivado Prednisona Pirimidina nucleósido Sangre Tratamiento asociado Vindesina Enzima Hemopatía maligna Isomerases Linfoproliferativo síndrome
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R04 Combined treatments (chemotherapy of immunotherapy associated with an other treatment)
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 13661788
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1200/JCO.2002.02.125 
https://dx.doi.org/10.1200/JCO.2002.02.125
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2002.02.125\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:96:\"Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2472\";s:8:\"\u0000*\u0000epage\";s:4:\"2479\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"GISSELBRECHT\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Christian\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:12:\"LEPAGE, Eric\";i:1;s:16:\"HERMINE, Olivier\";i:2;s:13:\"REYES, F\u00e9lix\";i:3;s:15:\"MOLINA, Thierry\";i:4;s:14:\"QUESNEL, Bruno\";i:5;s:15:\"FILLET, Georges\";i:6;s:16:\"LEDERLIN, Pierre\";i:7;s:18:\"COIFFIER, Bertrand\";i:8;s:13:\"TILLY, Herv\u00e9\";i:9;s:13:\"GABARRE, Jean\";i:10;s:18:\"GUILMIN, Francoise\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:96:\"Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2002.02.125\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:96:\"Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2472\";s:8:\"\u0000*\u0000epage\";s:4:\"2479\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"GISSELBRECHT\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Christian\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:12:\"LEPAGE, Eric\";i:1;s:16:\"HERMINE, Olivier\";i:2;s:13:\"REYES, F\u00e9lix\";i:3;s:15:\"MOLINA, Thierry\";i:4;s:14:\"QUESNEL, Bruno\";i:5;s:15:\"FILLET, Georges\";i:6;s:16:\"LEDERLIN, Pierre\";i:7;s:18:\"COIFFIER, Bertrand\";i:8;s:13:\"TILLY, Herv\u00e9\";i:9;s:13:\"GABARRE, Jean\";i:10;s:18:\"GUILMIN, Francoise\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:96:\"Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2002.02.125\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2002.02.125\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:96:\"Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2472\";s:8:\"\u0000*\u0000epage\";s:4:\"2479\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"GISSELBRECHT\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Christian\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:12:\"LEPAGE, Eric\";i:1;s:16:\"HERMINE, Olivier\";i:2;s:13:\"REYES, F\u00e9lix\";i:3;s:15:\"MOLINA, Thierry\";i:4;s:14:\"QUESNEL, Bruno\";i:5;s:15:\"FILLET, Georges\";i:6;s:16:\"LEDERLIN, Pierre\";i:7;s:18:\"COIFFIER, Bertrand\";i:8;s:13:\"TILLY, Herv\u00e9\";i:9;s:13:\"GABARRE, Jean\";i:10;s:18:\"GUILMIN, Francoise\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:96:\"Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2002.02.125\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:96:\"Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2472\";s:8:\"\u0000*\u0000epage\";s:4:\"2479\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"GISSELBRECHT\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Christian\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:12:\"LEPAGE, Eric\";i:1;s:16:\"HERMINE, Olivier\";i:2;s:13:\"REYES, F\u00e9lix\";i:3;s:15:\"MOLINA, Thierry\";i:4;s:14:\"QUESNEL, Bruno\";i:5;s:15:\"FILLET, Georges\";i:6;s:16:\"LEDERLIN, Pierre\";i:7;s:18:\"COIFFIER, Bertrand\";i:8;s:13:\"TILLY, Herv\u00e9\";i:9;s:13:\"GABARRE, Jean\";i:10;s:18:\"GUILMIN, Francoise\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:96:\"Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2002.02.125\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:96:\"Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2472\";s:8:\"\u0000*\u0000epage\";s:4:\"2479\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"GISSELBRECHT\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Christian\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:12:\"LEPAGE, Eric\";i:1;s:16:\"HERMINE, Olivier\";i:2;s:13:\"REYES, F\u00e9lix\";i:3;s:15:\"MOLINA, Thierry\";i:4;s:14:\"QUESNEL, Bruno\";i:5;s:15:\"FILLET, Georges\";i:6;s:16:\"LEDERLIN, Pierre\";i:7;s:18:\"COIFFIER, Bertrand\";i:8;s:13:\"TILLY, Herv\u00e9\";i:9;s:13:\"GABARRE, Jean\";i:10;s:18:\"GUILMIN, Francoise\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:96:\"Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
